IHEEZO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iheezo, and what generic alternatives are available?
Iheezo is a drug marketed by Harrow Eye and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-two patent family members in twenty-two countries.
The generic ingredient in IHEEZO is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iheezo
A generic version of IHEEZO was approved as chloroprocaine hydrochloride by HIKMA on September 9th, 1998.
Summary for IHEEZO
International Patents: | 22 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 815 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for IHEEZO |
What excipients (inactive ingredients) are in IHEEZO? | IHEEZO excipients list |
DailyMed Link: | IHEEZO at DailyMed |
Pharmacology for IHEEZO
Drug Class | Ester Local Anesthetic |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for IHEEZO
US Patents and Regulatory Information for IHEEZO
IHEEZO is protected by one US patents and one FDA Regulatory Exclusivity.
Patents protecting IHEEZO
Topical formulations of chloroprocaine and methods of using same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF INDUCING OCULAR ANESTHESIA
FDA Regulatory Exclusivity protecting IHEEZO
NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | IHEEZO | chloroprocaine hydrochloride | GEL;OPHTHALMIC | 216227-001 | Sep 27, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Harrow Eye | IHEEZO | chloroprocaine hydrochloride | GEL;OPHTHALMIC | 216227-001 | Sep 27, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IHEEZO
See the table below for patents covering IHEEZO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2019053657 | ⤷ Try a Trial | |
Singapore | 11202000992R | TOPICAL FORMULATIONS OF CHLOROPROCAINE | ⤷ Try a Trial |
Colombia | 2020002985 | Formulaciones tópicas de cloroprocaína | ⤷ Try a Trial |
China | 111163756 | 氯普鲁卡因的局部制剂 (TOPICAL FORMULATIONS OF CHLOROPROCAINE) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |